Stockscreener 앱 받기
15.25
1.33%
0.20
시간 외 거래:
15.25
Amylyx Pharmaceuticals Inc 주식(AMLX)의 최신 뉴스
Amylyx Pharmaceuticals Eyes Q3 Phase 3 Avexitide Readout as PBH Launch Plans Take Shape - Yahoo Finance
Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026 - BioSpace
Amylyx (NASDAQ: AMLX) director receives 24,372 stock options grant - Stock Titan
Amylyx (AMLX) director Karen Firestone receives 24,372 stock options grant - Stock Titan
Amylyx (NASDAQ: AMLX) director receives 24,372-share stock option grant - Stock Titan
Amylyx (NASDAQ: AMLX) director awarded 24,372 stock options at $14.31 strike - Stock Titan
Amylyx (AMLX) director Paul Fonteyne receives grant of 24,372 stock options - Stock Titan
Claim your share of the $6.5M Amylyx Pharmaceuticals securities class action settlement - Claim Depot
Post-bariatric hypoglycemia toll, avexitide trial design at ENDO 2026 - Stock Titan
H.C. Wainwright reiterates Amylyx stock rating on PBH trial insights By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Amylyx stock rating on PBH trial insights - Investing.com
Amylyx earnings on deck ahead of pivotal avexitide trial data By Investing.com - Investing.com Nigeria
Amylyx Pharmaceuticals eyes phase 3 AVEXITIDE readout as 2027 launch comes into focus - MSN
Amylyx Pharmaceuticals (NASDAQ: AMLX) investors approve directors, auditor and say-on-pay - Stock Titan
A Look At Amylyx Pharmaceuticals (AMLX) Valuation After Its Recent Share Price Rebound - Yahoo Finance
AMLX Stock Price, Quote & Chart | AMYLYX PHARMACEUTICALS INC (NASDAQ:AMLX) - ChartMill
Amylyx Pharmaceuticals (AMLX) Gains 3.36% as Shares Approach ResistanceWatchlist Stock Ideas - thelegaladvocate.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biohaven Ltd. (BHVN) and Immix Biopharma (IMMX) - The Globe and Mail
Amylyx director Karen Firestone purchases $51,338 of common stock. By Investing.com - Investing.com Nigeria
Amylyx director Karen Firestone purchases $51,338 of common stock. - Investing.com
Director Karen Firestone adds Amylyx Pharmaceuticals (AMLX) shares - Stock Titan
Amylyx gets FDA fast track status for ALS treatment - MSN
Amylyx Pharmaceuticals (AMLX) Slips 2.5% as Biotech Sector Faces Renewed ScrutinyAAII Bullish - thelegaladvocate.com
Amylyx Stock: Why the Full Pipeline Story Matters - MarketBeat
Guggenheim Initiates Coverage of Amylyx Pharmaceuticals (AMLX) with Buy Recommendation - MSN
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer FRATES JAMES M - Moomoo
Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 2026 Results and Pipeline Progress - Insider Monkey
Amylyx Pharmaceuticals, Inc.Common Stock (NQ: AMLX - FinancialContent
Mizuho Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $21 - Moomoo
Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation - BioSpace
Teva Pharmaceutical (TEVA) Reports Q1 Beat, Plans Amylyx Deal - Yahoo Finance
Number of shareholders of Amylyx Pharmaceuticals, Inc. – BOATS:AMLX - TradingView
Perceptive group holds 8.28M shares of Amylyx (AMLX) in Schedule 13G/A - Stock Titan
Amylyx publishes phase 2 Wolfram syndrome trial results - Investing.com
Amylyx publishes phase 2 Wolfram syndrome trial results By Investing.com - Investing.com Nigeria
Contributor: Fuel drug development, not Big Pharma's profits - AOL.com
B of A Securities Maintains Amylyx Pharmaceuticals (AMLX) Buy Recommendation - MSN
0.95%
1.13%
자본화:
|
볼륨(24시간):